학술논문

Nivolumab plus chemotherapy or ipilimumab versus chemotherapy in patients with advanced esophageal squamous cell carcinoma (CheckMate 648): 29-month follow-up from a randomized, open-label, phase III trial
Document Type
Article
Source
In: Cancer Medicine. (Cancer Medicine, May 2024, 13(9))
Subject
Language
English
ISSN
20457634